カテゴリ： QYResearch, 世界, 医療/バイオ

慢性疼痛管理薬の世界市場2025年：オピオイド、非麻薬性鎮痛薬、その他

■ 英語タイトル：Global Chronic Pain Management Drugs Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8723）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8723
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[慢性疼痛管理薬の世界市場2025年：オピオイド、非麻薬性鎮痛薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は慢性疼痛管理薬のグローバル市場について調査・分析し、世界の慢性疼痛管理薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（オピオイド、非麻薬性鎮痛薬、その他）、用途別セグメント分析（病院、診療所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer Inc.、Depomed Inc.、Endo International plc.、Purdue Pharma L.P.、Novartis AG、AstraZeneca plc.、Johnson and Johnson Services Inc.、Merck & Co.、Abbott Laboratories、GlaxoSmithKline plc.、Teva Pharmaceutical Industries Ltd.などが含まれています。慢性疼痛管理薬のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、慢性疼痛管理薬市場規模を算出する際に考慮しました。

・慢性疼痛管理薬市場の概要
- 慢性疼痛管理薬の種類別セグメント
- 世界の慢性疼痛管理薬市場規模：タイプ別分析（オピオイド、非麻薬性鎮痛薬、その他）
- 慢性疼痛管理薬の用途別セグメント
- 世界の慢性疼痛管理薬市場規模：用途別分析（病院、診療所、その他）
- 世界の慢性疼痛管理薬市場規模予測（2020年-2031年）

・慢性疼痛管理薬市場の成長トレンド
- 慢性疼痛管理薬の地域別市場規模（2020年-2031年）
- 慢性疼痛管理薬市場ダイナミクス
- 慢性疼痛管理薬の業界動向
- 慢性疼痛管理薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：オピオイド、非麻薬性鎮痛薬、その他
- 世界の慢性疼痛管理薬のタイプ別市場規模（2020年-2025年）
- 世界の慢性疼痛管理薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所、その他
- 世界の慢性疼痛管理薬の用途別市場規模（2020年-2025年）
- 世界の慢性疼痛管理薬の用途別市場規模（2024年-2029年）

・慢性疼痛管理薬の地域別市場規模
- 北米の慢性疼痛管理薬市場規模（2020年-2031年）
- 米国の慢性疼痛管理薬市場規模（2020年-2031年）
- ヨーロッパの慢性疼痛管理薬市場規模（2020年-2031年）
- アジア太平洋の慢性疼痛管理薬市場規模（2020年-2031年）
- 中国の慢性疼痛管理薬市場規模（2020年-2031年）
- 日本の慢性疼痛管理薬市場規模（2020年-2031年）
- 韓国の慢性疼痛管理薬市場規模（2020年-2031年）
- インドの慢性疼痛管理薬市場規模（2020年-2031年）
- オーストラリアの慢性疼痛管理薬市場規模（2020年-2031年）
- 中南米の慢性疼痛管理薬市場規模（2020年-2031年）
- 中東・アフリカの慢性疼痛管理薬市場規模（2020年-2031年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer Inc.、Depomed Inc.、Endo International plc.、Purdue Pharma L.P.、Novartis AG、AstraZeneca plc.、Johnson and Johnson Services Inc.、Merck & Co.、Abbott Laboratories、GlaxoSmithKline plc.、Teva Pharmaceutical Industries Ltd.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Chronic Pain Management Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Chronic Pain Management Drugs is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Chronic Pain Management Drugs is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Chronic Pain Management Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global companies of Chronic Pain Management Drugs include Pfizer Inc., Depomed Inc., Endo International plc., Purdue Pharma L.P., Novartis AG, AstraZeneca plc., Johnson and Johnson Services Inc., Merck & Co. and Abbott Laboratories, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chronic Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Pain Management Drugs.
The Chronic Pain Management Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Pain Management Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer Inc.
Depomed Inc.
Endo International plc.
Purdue Pharma L.P.
Novartis AG
AstraZeneca plc.
Johnson and Johnson Services Inc.
Merck & Co.
Abbott Laboratories
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Opioids
Non-narcotic Analgesic
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Pain Management Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Opioids
1.2.3 Non-narcotic Analgesic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chronic Pain Management Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Pain Management Drugs Market Perspective (2020-2031)
2.2 Chronic Pain Management Drugs Growth Trends by Region
2.2.1 Global Chronic Pain Management Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Pain Management Drugs Historic Market Size by Region (2020-2025)
2.2.3 Chronic Pain Management Drugs Forecasted Market Size by Region (2026-2031)
2.3 Chronic Pain Management Drugs Market Dynamics
2.3.1 Chronic Pain Management Drugs Industry Trends
2.3.2 Chronic Pain Management Drugs Market Drivers
2.3.3 Chronic Pain Management Drugs Market Challenges
2.3.4 Chronic Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Pain Management Drugs Players by Revenue
3.1.1 Global Top Chronic Pain Management Drugs Players by Revenue (2020-2025)
3.1.2 Global Chronic Pain Management Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Pain Management Drugs Revenue
3.4 Global Chronic Pain Management Drugs Market Concentration Ratio
3.4.1 Global Chronic Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Pain Management Drugs Revenue in 2022
3.5 Chronic Pain Management Drugs Key Players Head office and Area Served
3.6 Key Players Chronic Pain Management Drugs Product Solution and Service
3.7 Date of Enter into Chronic Pain Management Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Pain Management Drugs Breakdown Data by Type
4.1 Global Chronic Pain Management Drugs Historic Market Size by Type (2020-2025)
4.2 Global Chronic Pain Management Drugs Forecasted Market Size by Type (2026-2031)
5 Chronic Pain Management Drugs Breakdown Data by Application
5.1 Global Chronic Pain Management Drugs Historic Market Size by Application (2020-2025)
5.2 Global Chronic Pain Management Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Pain Management Drugs Market Size (2020-2031)
6.2 North America Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Pain Management Drugs Market Size by Country (2020-2025)
6.4 North America Chronic Pain Management Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Pain Management Drugs Market Size (2020-2031)
7.2 Europe Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Pain Management Drugs Market Size by Country (2020-2025)
7.4 Europe Chronic Pain Management Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Management Drugs Market Size (2020-2031)
8.2 Asia-Pacific Chronic Pain Management Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Pain Management Drugs Market Size (2020-2031)
9.2 Latin America Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Pain Management Drugs Market Size by Country (2020-2025)
9.4 Latin America Chronic Pain Management Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Management Drugs Market Size (2020-2031)
10.2 Middle East & Africa Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Chronic Pain Management Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Depomed Inc.
11.2.1 Depomed Inc. Company Detail
11.2.2 Depomed Inc. Business Overview
11.2.3 Depomed Inc. Chronic Pain Management Drugs Introduction
11.2.4 Depomed Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.2.5 Depomed Inc. Recent Development
11.3 Endo International plc.
11.3.1 Endo International plc. Company Detail
11.3.2 Endo International plc. Business Overview
11.3.3 Endo International plc. Chronic Pain Management Drugs Introduction
11.3.4 Endo International plc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.3.5 Endo International plc. Recent Development
11.4 Purdue Pharma L.P.
11.4.1 Purdue Pharma L.P. Company Detail
11.4.2 Purdue Pharma L.P. Business Overview
11.4.3 Purdue Pharma L.P. Chronic Pain Management Drugs Introduction
11.4.4 Purdue Pharma L.P. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.4.5 Purdue Pharma L.P. Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Chronic Pain Management Drugs Introduction
11.5.4 Novartis AG Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.5.5 Novartis AG Recent Development
11.6 AstraZeneca plc.
11.6.1 AstraZeneca plc. Company Detail
11.6.2 AstraZeneca plc. Business Overview
11.6.3 AstraZeneca plc. Chronic Pain Management Drugs Introduction
11.6.4 AstraZeneca plc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.6.5 AstraZeneca plc. Recent Development
11.7 Johnson and Johnson Services Inc.
11.7.1 Johnson and Johnson Services Inc. Company Detail
11.7.2 Johnson and Johnson Services Inc. Business Overview
11.7.3 Johnson and Johnson Services Inc. Chronic Pain Management Drugs Introduction
11.7.4 Johnson and Johnson Services Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.7.5 Johnson and Johnson Services Inc. Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Detail
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Chronic Pain Management Drugs Introduction
11.8.4 Merck & Co. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.8.5 Merck & Co. Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Detail
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Chronic Pain Management Drugs Introduction
11.9.4 Abbott Laboratories Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.9.5 Abbott Laboratories Recent Development
11.10 GlaxoSmithKline plc.
11.10.1 GlaxoSmithKline plc. Company Detail
11.10.2 GlaxoSmithKline plc. Business Overview
11.10.3 GlaxoSmithKline plc. Chronic Pain Management Drugs Introduction
11.10.4 GlaxoSmithKline plc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.10.5 GlaxoSmithKline plc. Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Pain Management Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Opioids
Table 3. Key Players of Non-narcotic Analgesic
Table 4. Key Players of Others
Table 5. Global Chronic Pain Management Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Chronic Pain Management Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Chronic Pain Management Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Chronic Pain Management Drugs Market Share by Region (2020-2025)
Table 9. Global Chronic Pain Management Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Chronic Pain Management Drugs Market Share by Region (2026-2031)
Table 11. Chronic Pain Management Drugs Market Trends
Table 12. Chronic Pain Management Drugs Market Drivers
Table 13. Chronic Pain Management Drugs Market Challenges
Table 14. Chronic Pain Management Drugs Market Restraints
Table 15. Global Chronic Pain Management Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Chronic Pain Management Drugs Market Share by Players (2020-2025)
Table 17. Global Top Chronic Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Management Drugs as of 2022)
Table 18. Ranking of Global Top Chronic Pain Management Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Chronic Pain Management Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Pain Management Drugs Product Solution and Service
Table 22. Date of Enter into Chronic Pain Management Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Pain Management Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Chronic Pain Management Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Chronic Pain Management Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Chronic Pain Management Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Chronic Pain Management Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Chronic Pain Management Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Chronic Pain Management Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Chronic Pain Management Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Chronic Pain Management Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Inc. Company Detail
Table 48. Pfizer Inc. Business Overview
Table 49. Pfizer Inc. Chronic Pain Management Drugs Product
Table 50. Pfizer Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 51. Pfizer Inc. Recent Development
Table 52. Depomed Inc. Company Detail
Table 53. Depomed Inc. Business Overview
Table 54. Depomed Inc. Chronic Pain Management Drugs Product
Table 55. Depomed Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 56. Depomed Inc. Recent Development
Table 57. Endo International plc. Company Detail
Table 58. Endo International plc. Business Overview
Table 59. Endo International plc. Chronic Pain Management Drugs Product
Table 60. Endo International plc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 61. Endo International plc. Recent Development
Table 62. Purdue Pharma L.P. Company Detail
Table 63. Purdue Pharma L.P. Business Overview
Table 64. Purdue Pharma L.P. Chronic Pain Management Drugs Product
Table 65. Purdue Pharma L.P. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 66. Purdue Pharma L.P. Recent Development
Table 67. Novartis AG Company Detail
Table 68. Novartis AG Business Overview
Table 69. Novartis AG Chronic Pain Management Drugs Product
Table 70. Novartis AG Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 71. Novartis AG Recent Development
Table 72. AstraZeneca plc. Company Detail
Table 73. AstraZeneca plc. Business Overview
Table 74. AstraZeneca plc. Chronic Pain Management Drugs Product
Table 75. AstraZeneca plc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 76. AstraZeneca plc. Recent Development
Table 77. Johnson and Johnson Services Inc. Company Detail
Table 78. Johnson and Johnson Services Inc. Business Overview
Table 79. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Product
Table 80. Johnson and Johnson Services Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 81. Johnson and Johnson Services Inc. Recent Development
Table 82. Merck & Co. Company Detail
Table 83. Merck & Co. Business Overview
Table 84. Merck & Co. Chronic Pain Management Drugs Product
Table 85. Merck & Co. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 86. Merck & Co. Recent Development
Table 87. Abbott Laboratories Company Detail
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Chronic Pain Management Drugs Product
Table 90. Abbott Laboratories Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 91. Abbott Laboratories Recent Development
Table 92. GlaxoSmithKline plc. Company Detail
Table 93. GlaxoSmithKline plc. Business Overview
Table 94. GlaxoSmithKline plc. Chronic Pain Management Drugs Product
Table 95. GlaxoSmithKline plc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 96. GlaxoSmithKline plc. Recent Development
Table 97. Teva Pharmaceutical Industries Ltd. Company Detail
Table 98. Teva Pharmaceutical Industries Ltd. Business Overview
Table 99. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Product
Table 100. Teva Pharmaceutical Industries Ltd. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
Table 101. Teva Pharmaceutical Industries Ltd. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Pain Management Drugs Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Chronic Pain Management Drugs Market Share by Type: 2022 VS 2029
Figure 3. Opioids Features
Figure 4. Non-narcotic Analgesic Features
Figure 5. Others Features
Figure 6. Global Chronic Pain Management Drugs Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 7. Global Chronic Pain Management Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Chronic Pain Management Drugs Report Years Considered
Figure 12. Global Chronic Pain Management Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Chronic Pain Management Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Chronic Pain Management Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Chronic Pain Management Drugs Market Share by Players in 2024
Figure 16. Global Top Chronic Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Management Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Pain Management Drugs Revenue in 2024
Figure 18. North America Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Chronic Pain Management Drugs Market Share by Country (2020-2031)
Figure 20. United States Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Chronic Pain Management Drugs Market Share by Country (2020-2031)
Figure 24. Germany Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Chronic Pain Management Drugs Market Share by Region (2020-2031)
Figure 32. China Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Chronic Pain Management Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Chronic Pain Management Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Pfizer Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 47. Depomed Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 48. Endo International plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 49. Purdue Pharma L.P. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 51. AstraZeneca plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 52. Johnson and Johnson Services Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 53. Merck & Co. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 54. Abbott Laboratories Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 55. GlaxoSmithKline plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

※参考情報

慢性疼痛管理薬は、長期間にわたる持続的な痛みを緩和する目的で使用される薬剤の総称です。慢性疼痛とは、一般的には3ヶ月以上続く痛みを指し、様々な疾患や原因によって引き起こされます。このような痛みは、身体的な負担だけでなく、心理的、社会的な影響も大きく、患者の生活の質を著しく低下させることがあります。そのため、慢性疼痛の管理には適切な薬物療法が重要です。

慢性疼痛管理薬の定義は、その名の通り、慢性疼痛を軽減または管理するために投与される薬です。この分類には多様な薬剤が含まれ、それぞれの薬剤が異なるメカニズムで働くため、患者の症状や背景に応じて選択されます。

これらの薬剤の特徴としては、まず、即効性のある鎮痛薬から、長期間にわたり効果を持続させる薬剤まで様々であることが挙げられます。急性の疼痛にはオピオイド系の薬剤や非ステロイド性抗炎症薬（NSAIDs）がしばしば使用されますが、慢性疼痛の場合は、抗うつ薬や抗けいれん薬も重要な選択肢となります。これらは神経の痛みを緩和する働きがあるため、特に神経障害性疼痛などに効果的です。

慢性疼痛管理薬は主に以下の種類に分類されます：

1. **非オピオイド鎮痛薬**：
これには、アセトアミノフェンやNSAIDsが含まれます。アセトアミノフェンは痛みを和らげる効果があり、副作用が少ないため、軽度から中等度の痛みに広く使用されます。一方、NSAIDsは炎症を抑える効果もあり、痛みの原因が炎症に関連している場合に特に効果的です。

2. **オピオイド系鎮痛薬**：
モルヒネやオキシコドンなどのオピオイドは、強い痛みを持つ患者に対して用いられます。これらの薬剤は中枢神経系に作用し、痛みの信号をブロックします。一方で、依存症や副作用のリスクが高いため、使用には注意が必要です。

3. **抗うつ薬**：
三環系抗うつ薬やSNRI（セロトニン-ノルアドレナリン再取り込み阻害薬）は、慢性疼痛管理において重要な役割を果たします。これらの薬剤は、痛みの感覚を調整する神経伝達物質に影響を与えることによって、疼痛を軽減します。

4. **抗けいれん薬**：
プレガバリンやガバペンチンなどの薬剤は、神経障害性疼痛の緩和に特に効果的です。これらの薬は、神経の過敏性を抑えることによって、痛みを和らげます。

5. **局所治療薬**：
薬剤が皮膚に塗布されることで作用する局所治療薬には、リドカインパッチやカプサイシンクリームなどがあり、特定の部位の疼痛を緩和するために用いられます。

6. **その他の治療法**：
一部の症例では、疼痛管理のためにステロイドや筋弛緩剤が併用されることもあります。また、最近では抗炎症作用を持つ生物製剤の使用も注目されています。

慢性疼痛管理薬の用途は、非常に広範囲に及びます。多くの慢性疾患、例えば、関節リウマチ、変形性関節症、線維筋痛症、糖尿病性神経障害などにおいて、これらの薬剤は内服されることが一般的です。さらに、がん患者における疼痛管理にも欠かせない要素です。このように、慢性疼痛管理薬は、多様な疾患において重要な治療手段となっています。

関連する技術としては、薬物療法のほかにも、医療機器や治療法の進展が関与しています。例えば、脊髄刺激装置や神経ブロックといった医療機器による疼痛緩和法は、薬物療法では効果が得られない患者に対して使用されることがあります。また、認知行動療法などの心理的アプローチも、慢性疼痛の管理において効果があるとされています。

慢性疼痛管理は、多方面からのアプローチが必要とされる分野です。個々の患者に対する薬剤の選択は、その人の病歴や疼痛の性質、生活の質を考慮しながら行われるべきです。将来的には、患者それぞれに最適な治療を提供するための個別化医療が進むことが期待されています。このような中で、慢性疼痛管理薬は、依然として重要な役割を果たし続けるでしょう。慢性疼痛に対する理解を深め、適切な管理方法を選ぶことが、より良い治療結果に導く鍵となります。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の疼痛管理治療市場2022年ｰ2031年：治療薬別（抗けいれん薬、抗うつ薬、麻酔薬、非ステロイド性抗炎症薬（NSAIDS）、オピオイド、抗けいれん薬、その他）
  • 神経障害性疼痛のグローバル市場（2023-2032）：抗うつ薬、抗けいれん薬、オピオイド、カプサイシン、その他
  • 局所鎮痛剤のグローバル市場：非オピオイド、オピオイド
  • 世界の鎮痛薬市場予測2024年-2032年：種類別（処方薬、一般用医薬品（OTC））、薬効分類別（オピオイド、NSAID、その他）、投与経路別（経口、非経口、局所、経皮、直腸）、疼痛種類別（筋骨格系、外科・外傷、癌、神経障害性、偏頭痛、産科、線維筋痛症、火傷による疼痛、歯科・顔面、小児、その他）、用途別（内用、外用）、地域別
  • がん支持療法薬のグローバル市場（2023-2032）：赤血球造血刺激因子、顆粒球コロニー刺激因子、制吐薬、ビスフォスフォネート、オピオイド、非ステロイド性抗炎症薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8723 )"慢性疼痛管理薬の世界市場2025年：オピオイド、非麻薬性鎮痛薬、その他" (英文：Global Chronic Pain Management Drugs Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。